Press releaseNewsfile
Anavex Life Sciences
AVXL · NASDAQ
$1.36+$0.11 (+8.80%)TodayMarket closed ·
Prev close $1.25
Latest news
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL
- Press releaseGlobe Newswire
Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies
- Press releaseNewsfile
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXL
- Press releaseNewsfile
Kaplan Fox Reminds Anavex Life Sciences Corp. (AVXL) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 30, 2026
- Press releaseNewsfile
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXL
- Press releaseGlobe Newswire
ROSEN, RECOGNIZED TRIAL ATTORNEYS, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
- Press releaseNewsfile
ROSEN, A LEADING LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXL
- Press releaseNewsfile
Did You Lose Money Investing in Anavex Life Sciences Corp.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against AVXL
- Press releaseNewsfile
Kaplan Fox Encourages Anavex Life Sciences Corp. (AVXL) Investors to Contact the Firm Before the Deadline on November 30, 2026 for a Leadership Role
- Press releaseGlobe Newswire
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL
- Press releaseBusiness Wire
AVXL Investors: Anavex Life Sciences Corp. Shares Declined By $0.19 On August 31, 2026 – Contact Kirby McInerney LLP to Discuss Your Rights
- Press releaseNewsfile
Kaplan Fox Advises Anavex Life Sciences Corp. (AVXL) Investors to Act Before the Lead Plaintiff Deadline on November 30, 2026
- Press releaseGlobe Newswire
AVXL Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Anavex Life Sciences Corp. Class Action Lawsuit
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL
- Press releaseGlobe Newswire
Deadline Alert: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
- Press releaseNewsfile
Kaplan Fox Announces a Securities Class Action Filed Against Anavex Life Sciences Corp. (AVXL) - Lead Plaintiff Deadline is November 30, 2026
- Press releasePRNewswire
Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVXL
- Press releasePRNewswire
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
- Press releasePRNewswire
Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Press releaseBusiness Wire
Deadline Alert: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
- Press releasePRNewswire
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 30, 2026 in Anavex Life Sciences Corp. Lawsuit - AVXL
- Press releaseNewsfile
Kaplan Fox Encourages Anavex Life Sciences Corp. (AVXL) Investors with Significant Losses to Contact the Firm Before November 30, 2026
- Press releaseGlobe Newswire
AVXL INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Anavex Life Sciences Corp. Shareholders
- Press releaseGlobe Newswire
AVXL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
- Press releaseBusiness Wire
Deadline Approaching: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
- Press releasePRNewswire
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 30, 2026 - AVXL
- Press releaseNewsfile
Kaplan Fox & Kilsheimer LLP Alerts Anavex Life Sciences Corp. (AVXL) Investors to a Securities Class Action Deadline on November 30, 2026
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL
- Press releaseBusiness Wire
Deadline Soon: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
- News
Anavex Life Sciences Q3 EPS $0.08 Beats $(0.08) Estimate
- NewsAvi Kapoor
Crude Oil Moves Lower; Cintas Raises FY2026 Forecast
- NewsAvi Kapoor
Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsVandana Singh
Anavex Life Sciences Stock Crushed As European Alzheimer's Drug Filing Pulled After EMA Pushback
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
Earnings Scheduled For February 9, 2026
- News
Anavex Life Sciences's Earnings Outlook
- NewsAvi Kapoor
Marvell Posts Strong Q3 Earnings, Joins American Eagle, Microchip Technology, Box And Other Big Stocks Moving Higher On Wednesday
- NewsErica Kollmann
Top Stocks with Earnings This Week: Costco, MongoDB, Ulta and More
- News
Earnings Scheduled For November 25, 2025
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.